BC Partners is to sell its stake in Pharmathen to Partners Group in a deal that values the generic contract development and manufacturing organisation (CDMO) at around EUR 1.6bn.
BC sells Pharmathen to Partners Group in EUR 1.6bn deal
Most Popular
BC Partners is to sell its stake in Pharmathen to Partners Group in a deal that values the generic contract development and manufacturing organisation (CDMO) at around EUR 1.6bn.